Saturday, 20 April 2024
Protalix BioTherapeutics Inc.
AMEX : PLX
1.020 14 Oct 22 00:00 | Change: 0.01 | Open: 1.010 | High: 1.040 | Ask: 0.000 | Volume: 75,700 |
Change(%): 0.96 | Prev: 1.030 | Low: 1.010 | Bid: 0.000 | Avg vol: 0 |
00:26 | 17/3/18
Post Analyst
Protalix BioTherapeutics, Inc. is maintained at an average outperform rating by 4 stock analysts, and there are at least 3.65% of shares outstanding that are currently legally short sold.
more»
23:30 | 15/3/18
Post Analyst
Protalix BioTherapeutics, Inc. (NYSE:PLX) marched up 20.83% compared to a 52-week low price of $0.48. The shares were last seen trading -9.56% lower, taking the closing price at $0.58 on 03/14/2018.
more»
03:48 | 15/3/18
Seeking Alpha
Protalix announced the results of their phase 2 open label trial of OPRX-106 for the treatment of Ulcerative Colitis on March 13.
more»
03:37 | 15/3/18
Stocks Gallery
In latest trading activity; Protalix BioTherapeutics, Inc. (PLX) snatched the consideration from Investors, when its current damaging picture was seen that is promoting bad performance.
more»
01:00 | 15/3/18
StockNewsGazette
The shares of Protalix BioTherapeutics, Inc. have decreased by more than -3.01% this year alone. The shares recently went down by -4.28% or -$0.03 and now trades at $0.64.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |